Reduced cancer incidence, longer survival, and fewer metastases were also seen with GLP-1 use in patients with endometrial, bladder and prostate cancers, as well as in those with small intestine neoplasms and blood cancers, multiple studies found
GLP-1 promotes fullness and appetite control, while GIP supports insulin release and fat metabolism
L-carnitine is found in dietary sources (especially animal sources) and can also be synthesized in the liver, kidneys, and brain from the amino acids lysine and methionine
The GLP-1 agonist dosage was initiated at 0.6 mg/day and increased to 1.2 mg/day without an adverse event
BPC has shown in animal studies to counteract bilateral clamping of the common carotid arteries-induced stroke, sustained brain neuronal damages were resolved in rats as well as disturbed memory, locomotion, and coordination